Description
AOD-9604 is a synthetic fragment of the human growth hormone sequence studied in controlled laboratory environments for its interaction with beta-3 adrenergic receptors and lipid metabolism signaling pathways, independent of the broader growth-promoting effects associated with full-length GH.
Key Characteristics
- Synthetic C-terminal fragment of human growth hormone (hGH 177–191)
- Studied for selective interaction with beta-3 adrenergic receptors in lipid-related cell models
- Does not activate IGF-1 signaling pathways, making it useful for isolated lipolytic pathway analysis
- Compact peptide structure supports stability across a range of controlled laboratory conditions
- Commonly selected for research models focused on metabolic signaling without systemic GH activity
Handling and Storage
Consistent storage conditions are important for preserving compound integrity throughout a research period. It should be kept away from heat, moisture, and direct light. Controlled temperature environments help maintain structural stability and support reliable outcomes across analytical procedures.
FAQs
What is AOD-9604?
AOD-9604 is a synthetic fragment derived from the C-terminal region of human growth hormone, studied in laboratory settings for its selective interaction with lipid metabolism signaling pathways and beta-3 adrenergic receptor activity.
How does AOD-9604 differ from full-length growth hormone?
Unlike full-length hGH, AOD-9604 does not appear to activate IGF-1 signaling in cell-based models, making it a more targeted tool for researchers studying lipolytic pathways in isolation.
What research models is AOD-9604 typically used in?
AOD-9604 is most commonly selected for in vitro models examining lipolytic signaling and adipocyte behavior, as well as comparative studies where isolating beta-3 adrenergic activity without IGF-1 pathway interference is a key experimental requirement.
